Related references
Note: Only part of the references are listed.Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking
Brenda J. Green et al.
ANALYTICAL CHEMISTRY (2019)
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
Hirokazu Taniguchi et al.
NATURE COMMUNICATIONS (2019)
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer
Xiuwen Guan et al.
CANCER COMMUNICATIONS (2019)
Analogous detection of circulating tumor cells using the AccuCyte®CyteFinder® system and ISET system in patients with locally advanced and metastatic prostate cancer
Emma E. van der Toom et al.
PROSTATE (2018)
Size-based separation methods of circulating tumor cells
Si-Jie Hao et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter
Masaru Watanabe et al.
CANCER SCIENCE (2018)
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors
Julia Boshuizen et al.
NATURE MEDICINE (2018)
Epithelial and mesenchymal circulating tumor cell isolation and discrimination using dual-immunopatterned device with newly-developed anti-63B6 and anti-EpCAM
Yoon-Tae Kang et al.
SENSORS AND ACTUATORS B-CHEMICAL (2018)
Profiling Heterogeneous Circulating Tumor Cells (CTC) Populations in Pancreatic Cancer Using a Serial Microfluidic CTC Carpet Chip
Mina Zeinali et al.
ADVANCED BIOSYSTEMS (2018)
Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape
Malte Mohme et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications
Xiao-Xiang Jie et al.
ONCOTARGET (2017)
Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients
Satomi Yagi et al.
PLOS ONE (2017)
Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma
A. Strati et al.
ANNALS OF ONCOLOGY (2017)
Giving AXL the axe: targeting AXL in human malignancy
Carl M. Gay et al.
BRITISH JOURNAL OF CANCER (2017)
Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution
Nikolas H. Stoecklein et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
ALK inhibitor resistance in ALKF1174L-driven neuroblastoma is associated with AXL activation and induction of EMT
D. N. Debruyne et al.
ONCOGENE (2016)
The biology of circulating tumor cells
K. Pantel et al.
ONCOGENE (2016)
Clusters of circulating tumor cells traverse capillary-sized vessels
Sam H. Au et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Correlation between epidermal growth factor receptor tyrosine kinase inhibitor efficacy and circulating tumor cell levels in patients with advanced non-small cell lung cancer
Wenjie He et al.
ONCOTARGETS AND THERAPY (2016)
Reprogramming the immunological microenvironment through radiation and targeting Axl
Todd A. Aguilera et al.
NATURE COMMUNICATIONS (2016)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: a report from the PETRUS prospective study
Christophe Massard et al.
ONCOTARGET (2016)
Characterization of different CTC subpopulations in non-small cell lung cancer
Annkathrin Hanssen et al.
SCIENTIFIC REPORTS (2016)
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
Chiara Nicolazzo et al.
SCIENTIFIC REPORTS (2016)
The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells
Alexandra C. Koelbl et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Frequent expression of PD-L1 on circulating breast cancer cells
Martine Mazel et al.
MOLECULAR ONCOLOGY (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
Marta Pestrin et al.
MOLECULAR ONCOLOGY (2015)
Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
Shiyang Wu et al.
PLOS ONE (2015)
Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research
P. K. Grover et al.
ANNALS OF ONCOLOGY (2014)
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Nicola Aceto et al.
CELL (2014)
Enrichment and enumeration of circulating tumor cells by efficient depletion of leukocyte fractions
Shiyang Wu et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Mueller et al.
NATURE COMMUNICATIONS (2014)
AXL kinase as a novel target for cancer therapy
Xiaoliang Wu et al.
ONCOTARGET (2014)
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Douglas K. Graham et al.
NATURE REVIEWS CANCER (2014)
OPINION Challenges in circulating tumour cell research
Catherine Alix-Panabieres et al.
NATURE REVIEWS CANCER (2014)
Microcavity Array System for Size-Based Enrichment of Circulating Tumor Cells from the Blood of Patients with Small-Cell Lung Cancer
Masahito Hosokawa et al.
ANALYTICAL CHEMISTRY (2013)
Cisplatin influences acquisition of resistance to molecular-targeted agents through epithelial-mesenchymal transition-like changes
Maki Kurokawa et al.
CANCER SCIENCE (2013)
Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non-Small-Cell Lung Cancer
Emma Pailler et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Size-Based Isolation of Circulating Tumor Cells in Lung Cancer Patients Using a Microcavity Array System
Masahito Hosokawa et al.
PLOS ONE (2013)
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer
Chun-Liang Chen et al.
PROSTATE (2013)
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
Matthew G. Krebs et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Considerations in the development of circulating tumor cell technology for clinical use
David R. Parkinson et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
Intra-tumour heterogeneity: a looking glass for cancer?
Andriy Marusyk et al.
NATURE REVIEWS CANCER (2012)
Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer
A. Lecharpentier et al.
BRITISH JOURNAL OF CANCER (2011)
Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method
Veronique Hofman et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
Andrew J. Armstrong et al.
MOLECULAR CANCER RESEARCH (2011)
Clinical relevance and biology of circulating tumor cells
Natalia Bednarz-Knoll et al.
BREAST CANCER RESEARCH (2011)
AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer
Erinn B. Rankin et al.
CANCER RESEARCH (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia
Chih-Chen Hong et al.
CANCER LETTERS (2008)
Circulating tumor cells and bone marrow micrometastasis
Catherine Alix-Panabieres et al.
CLINICAL CANCER RESEARCH (2008)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Isolation by size of epithelial tumor cells - A new method for the immunomorphological and molecular characterization of circulating tumor cells
G Vona et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
